208 related articles for article (PubMed ID: 33015739)
1. DeepCOMO: from structure-activity relationship diagnostics to generative molecular design using the compound optimization monitor methodology.
Yonchev D; Bajorath J
J Comput Aided Mol Des; 2020 Dec; 34(12):1207-1218. PubMed ID: 33015739
[TBL] [Abstract][Full Text] [Related]
2. From SAR Diagnostics to Compound Design: Development Chronology of the Compound Optimization Monitor (COMO) Method.
Yonchev D; Vogt M; Bajorath J
Mol Inform; 2020 Dec; 39(12):e2000046. PubMed ID: 32282989
[TBL] [Abstract][Full Text] [Related]
3. The SAR Matrix Method and an Artificially Intelligent Variant for the Identification and Structural Organization of Analog Series, SAR Analysis, and Compound Design.
Yoshimori A; Bajorath J
Mol Inform; 2020 Dec; 39(12):e2000045. PubMed ID: 32271994
[TBL] [Abstract][Full Text] [Related]
4. Computational Method to Evaluate Progress in Lead Optimization.
Vogt M; Yonchev D; Bajorath J
J Med Chem; 2018 Dec; 61(23):10895-10900. PubMed ID: 30499667
[TBL] [Abstract][Full Text] [Related]
5. A data mining method to facilitate SAR transfer.
Wassermann AM; Bajorath J
J Chem Inf Model; 2011 Aug; 51(8):1857-66. PubMed ID: 21774471
[TBL] [Abstract][Full Text] [Related]
6. Adapting the DeepSARM approach for dual-target ligand design.
Yoshimori A; Hu H; Bajorath J
J Comput Aided Mol Des; 2021 May; 35(5):587-600. PubMed ID: 33712972
[TBL] [Abstract][Full Text] [Related]
7. Graph-based generative models for de Novo drug design.
Xia X; Hu J; Wang Y; Zhang L; Liu Z
Drug Discov Today Technol; 2019 Dec; 32-33():45-53. PubMed ID: 33386094
[TBL] [Abstract][Full Text] [Related]
8. Integrating computational lead optimization diagnostics with analog design and candidate selection.
Yonchev D; Bajorath J
Future Sci OA; 2020 Jan; 6(3):FSO451. PubMed ID: 32140250
[TBL] [Abstract][Full Text] [Related]
9. Informatics and modeling challenges in fragment-based drug discovery.
Hubbard RE; Chen I; Davis B
Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
[TBL] [Abstract][Full Text] [Related]
10. Dose Predictions for Drug Design.
Maurer TS; Smith D; Beaumont K; Di L
J Med Chem; 2020 Jun; 63(12):6423-6435. PubMed ID: 31913040
[TBL] [Abstract][Full Text] [Related]
11. Systematic mining of analog series with related core structures in multi-target activity space.
Gupta-Ostermann D; Hu Y; Bajorath J
J Comput Aided Mol Des; 2013 Aug; 27(8):665-74. PubMed ID: 23975272
[TBL] [Abstract][Full Text] [Related]
12. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series.
Duffy BC; Zhu L; Decornez H; Kitchen DB
Bioorg Med Chem; 2012 Sep; 20(18):5324-42. PubMed ID: 22938785
[TBL] [Abstract][Full Text] [Related]
13. De novo design - hop(p)ing against hope.
Schneider G
Drug Discov Today Technol; 2013 Dec; 10(4):e453-60. PubMed ID: 24451634
[TBL] [Abstract][Full Text] [Related]
14. Trends in Deep Learning for Property-driven Drug Design.
Born J; Manica M
Curr Med Chem; 2021; 28(38):7862-7886. PubMed ID: 34325627
[TBL] [Abstract][Full Text] [Related]
15. Designing around Structural Alerts in Drug Discovery.
Kalgutkar AS
J Med Chem; 2020 Jun; 63(12):6276-6302. PubMed ID: 31497963
[TBL] [Abstract][Full Text] [Related]
16. Graph mining for SAR transfer series.
Gupta-Ostermann D; Wawer M; Wassermann AM; Bajorath J
J Chem Inf Model; 2012 Apr; 52(4):935-42. PubMed ID: 22436016
[TBL] [Abstract][Full Text] [Related]
17. The influence of the 'organizational factor' on compound quality in drug discovery.
Leeson PD; St-Gallay SA
Nat Rev Drug Discov; 2011 Sep; 10(10):749-65. PubMed ID: 21959288
[TBL] [Abstract][Full Text] [Related]
18. Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space.
Meanwell NA
Chem Res Toxicol; 2016 Apr; 29(4):564-616. PubMed ID: 26974882
[TBL] [Abstract][Full Text] [Related]
19. Docking-based generative approaches in the search for new drug candidates.
Danel T; Łęski J; Podlewska S; Podolak IT
Drug Discov Today; 2023 Feb; 28(2):103439. PubMed ID: 36372330
[TBL] [Abstract][Full Text] [Related]
20. [Ligand efficiency and lead optimization].
Guo ZR
Yao Xue Xue Bao; 2013 Dec; 48(12):1755-62. PubMed ID: 24689231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
